Consainsights logo

Topical Drug Delivery Market Size, Share, Industry Trends and Forecast to 2030

Topical Drug Delivery Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

Topical Drug Delivery Market Size & CAGR in 2021

The global topical drug delivery market is estimated to have a market size of USD 125.6 billion in 2021 with a Compound Annual Growth Rate (CAGR) of 6.8% from 2021 to 2028. This growth is attributed to the rising prevalence of chronic diseases, increasing focus on personalized medicine, and advancements in drug delivery technologies.

COVID-19 Impact on the Topical Drug Delivery Market

The COVID-19 pandemic has significantly impacted the topical drug delivery market. The disrupted supply chains, temporary closure of manufacturing units, and reduced patient visits to healthcare facilities have affected the market dynamics. However, the increased focus on research and development of topical drug delivery systems to combat the virus has created growth opportunities in the market.

Topical Drug Delivery Dynamics

The topical drug delivery market is driven by factors such as the growing geriatric population, increasing prevalence of skin diseases, and the rising demand for targeted drug delivery systems. Advancements in nanotechnology and biologics have further accelerated the growth of the market. However, challenges related to regulatory approval processes and concerns regarding skin irritation remain key restraints for market growth.

Segments and Related Analysis

The topical drug delivery market is segmented based on type, route of administration, and end-user. On the basis of type, the market is categorized into semisolids, liquids, and solids. By route of administration, the market is divided into dermal, transdermal, and mucosal. End-users of topical drug delivery systems include hospitals, clinics, home care settings, and others.

By Region Analysis

Geographically, the topical drug delivery market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest market share due to the presence of key market players, high healthcare expenditure, and technological advancements. The Asia Pacific region is expected to grow at a rapid pace owing to the increasing patient population and rising investments in healthcare infrastructure.

Key Market Players and Competitive Landscape

Some of the key players in the topical drug delivery market include Johnson & Johnson, Novartis AG, GlaxoSmithKline plc, Valeant Pharmaceuticals International, Inc., and Bayer AG. These companies are actively involved in product development, mergers, acquisitions, and partnerships to strengthen their market position and expand their product portfolio. The competitive landscape of the market is characterized by intense competition and innovation.

Recent Happenings in the Topical Drug Delivery Market

In recent developments, Johnson & Johnson launched a new line of topical drug delivery products for dermatological conditions. Novartis AG announced a strategic partnership with a biotech company to develop innovative transdermal drug delivery systems. GlaxoSmithKline plc introduced a novel topical formulation for pain management. Valeant Pharmaceuticals International, Inc. acquired a startup specializing in advanced drug delivery technologies. Bayer AG collaborated with a research institute to enhance the efficacy of topical drug delivery systems.

Frequently Asked Questions (FAQ):